DexCom, Inc. vs GoPro Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while GoPro Inc trades at $0.63 (market cap $114.41M). The key difference: DexCom, Inc. is far larger — about 295.3× GoPro Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | GPRO | |
|---|---|---|
Market Cap | $33.79B | $114.41M |
Sector | Health | Technology |
52-Week High | $89.53 | $2.88 |
52-Week Low | $54.84 | $0.62 |
Enterprise Value | $33.24B | $173.19M |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →